Pasar al contenido principal

MECANISMOS CELULARES Y FUNCIONES DE LA PLASTICIDAD SINAPTICA

PID2019-107677GB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD PABLO DE OLAVIDE, DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Synaptic vulnerability to amyloid-β and tau pathologies differentially disrupts emotional and memory neural circuits

  • Capilla López, Maria Dolores|||0000-0002-9483-4887
  • Deprada Fernández, Ángel|||0000-0002-7860-6307
  • Andrade-Talavera, Yuniesky|||0000-0002-5295-0169
  • Martínez Gallego, Irene|||0000-0002-8936-8201
  • Coatl-Cuaya, Heriberto|||0000-0003-4953-6562
  • Sotillo Sotillo, Paula
  • Rodríguez Álvarez, José|||0000-0001-8582-8082
  • Rodríguez Moreno, Antonio|||0000-0002-8078-6175
  • Parra-Damas, Arnaldo|||0000-0001-5683-060X
  • Saura Antolín, Carlos|||0000-0003-3692-5657
Alzheimer's disease (AD) is characterized by memory loss and neuropsychiatric symptoms associated with cerebral amyloid-β (Aβ) and tau pathologies, but whether and how these factors differentially disrupt neural circuits remains unclear. Here, we investigated the vulnerability of memory and emotional circuits to Aβ and tau pathologies in mice expressing mutant human amyloid precursor protein (APP), Tau or both APP/Tau in excitatory neurons. APP/Tau mice develop age- and sex-dependent Aβ and phosphorylated tau pathologies, the latter exacerbated at early stages, in vulnerable brain regions. Early memory deficits were associated with hippocampal tau pathology in Tau and APP/Tau mice, whereas anxiety and fear appeared linked to intracellular Aβ in the basolateral amygdala (BLA) of APP and APP/Tau mice. Transcriptome hippocampal profiling revealed gene changes affecting myelination and RNA processing in Tau mice, and inflammation and synaptic-related pathways in APP/Tau mice at 6 months. At 9 months, we detected common and region-specific changes in astrocytic, microglia and 63 AD-associated genes in the hippocampus and BLA of APP/Tau mice. Spatial learning deficits were associated with synaptic tau accumulation and synapse disruption in the hippocampus of Tau and APP/Tau mice, whereas emotional disturbances were linked to Aβ pathology but not synaptic tau in the BLA. Interestingly, Aβ and tau exhibited synergistic detrimental effects in long-term potentiation (LTP) in the hippocampus but they counteract with each other to mitigate LTP impairments in the amygdala. These findings indicate that Aβ and tau pathologies cause region-specific effects and synergize to induce synaptic dysfunction and immune responses, contributing to the differing vulnerability of memory and emotional neural circuits in AD.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Neuroligin-1 mutation associated with Alzheimer's disease produces memory and age-dependent impairments in hippocampal plasticity

  • Arias-Aragón, Francisco
  • Tristán Clavijo, E.
  • Martínez-Gallego, Irene
  • Robles Lanuza, Estefanía
  • Coatl-Cuaya, Heriberto
  • Martín-Cuevas, Celia
  • Sánchez-Hidalgo, Ana C.
  • Rodríguez-Moreno, Antonio
  • Martínez Mir, Amalia
  • Scholl, Francisco G.
Alzheimer's disease (AD) is characterized by memory impairments and age-dependent synapse loss. Experimental and clinical studies have shown decreased expression of the glutamatergic protein Neuroligin-1 (Nlgn1) in AD. However, the consequences of a sustained reduction of Nlgn1 are unknown. Here, we generated a knockin mouse that reproduces the NLGN1 Thr271fs mutation, identified in heterozygosis in a familial case of AD. We found that Nlgn1 Thr271fs mutation abolishes Nlgn1 expression in mouse brain. Importantly, heterozygous Nlgn1 Thr271fs mice showed delay-dependent amnesia for recognition memory. Electrophysiological recordings uncovered age-dependent impairments in basal synaptic transmission and long-term potentiation (LTP) in CA1 hippocampal neurons of heterozygous Nlgn1 Thr271fs mice. In contrast, homozygous Nlgn1 Thr271fs mice showed impaired fear-conditioning memory and normal basal synaptic transmission, suggesting unshared mechanisms for a partial or total loss of Nlgn1. These data suggest that decreased Nlgn1 may contribute to the synaptic and memory deficits in AD., This work was funded by grants from Ministerio de Ciencia, Innovación y Universidades (RTI2018-101886-B-100) and Junta de Andalucía (PROYEXCEL_00573) to FGS and AM-M, AEI/FEDER (PID2019107677GBI00) and Juan de Andalucía/FEDER (P20_00881) to A.R.-M. and co-funded by ERDF. We thank Sonia Carrasco-Poley for support with NeuN quantification. FA-A was the recipient of a fellowship from Ministerio de Economía, Industria y Competitividad (BES-2016-076579). IM-G was supported by Formación de Profesorado Universitario predoctoral fellowship from Ministerio de Universidades (FPU 17/04283). ER-L was a fellow from V Plan Propio de Investigación (Universidad de Sevilla). CM-C was the recipient of a Garantía Juvenil contract from Universidad de Sevilla. ACS-H received a fellowship from Junta de Andalucía (P11-CVI-7599)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Targeting galectin-3 to counteract spike-phase uncoupling of fast-spiking interneurons to gamma oscillations in Alzheimer's disease

  • Arroyo-García, Luis Enrique
  • Bachiller, Sara
  • Ruiz, Rocío
  • Boza-Serrano, Antonio
  • Rodríguez-Moreno, Antonio
  • Deierborg, Tomas
  • Andrade-Talavera, Yuniesky
  • Fisahn, André
[Background] Alzheimer's disease (AD) is a progressive multifaceted neurodegenerative disorder for which no disease-modifying treatment exists. Neuroinflammation is central to the pathology progression, with evidence suggesting that microglia-released galectin-3 (gal3) plays a pivotal role by amplifying neuroinflammation in AD. However, the possible involvement of gal3 in the disruption of neuronal network oscillations typical of AD remains unknown., [Methods] Here, we investigated the functional implications of gal3 signaling on experimentally induced gamma oscillations ex vivo (20–80 Hz) by performing electrophysiological recordings in the hippocampal CA3 area of wild-type (WT) mice and of the 5×FAD mouse model of AD. In addition, the recorded slices from WT mice under acute gal3 application were analyzed with RT-qPCR to detect expression of some neuroinflammation-related genes, and amyloid-β (Aβ) plaque load was quantified by immunostaining in the CA3 area of 6-month-old 5×FAD mice with or without Gal3 knockout (KO)., [Results] Gal3 application decreased gamma oscillation power and rhythmicity in an activity-dependent manner, which was accompanied by impairment of cellular dynamics in fast-spiking interneurons (FSNs) and pyramidal cells. We found that the gal3-induced disruption was mediated by the gal3 carbohydrate-recognition domain and prevented by the gal3 inhibitor TD139, which also prevented Aβ42-induced degradation of gamma oscillations. Furthermore, the 5×FAD mice lacking gal3 (5×FAD-Gal3KO) exhibited WT-like gamma network dynamics and decreased Aβ plaque load., [Conclusions] We report for the first time that gal3 impairs neuronal network dynamics by spike-phase uncoupling of FSNs, inducing a network performance collapse. Moreover, our findings suggest gal3 inhibition as a potential therapeutic strategy to counteract the neuronal network instability typical of AD and other neurological disorders encompassing neuroinflammation and cognitive decline., Open access funding provided by Karolinska Institute. This work was supported by the Swedish Research Council, the Swedish Brain Foundation, the Swedish Alzheimer Foundation, the Åhlén Foundation (AF), the Berger Foundation (TD), the Olle Engkvist Foundation (TD), G&K Kock Foundation (TD), the Strategic Research Area MultiPark at Lund University (TD), the Foundation for Geriatric Diseases at Karolinska Institutet, the Åhlén Foundation (YAT), Consejo Nacional de Ciencia y Tecnología (CONACYT) postdoctoral fellowships and StratNeuro program at Karolinska Institutet (LEAG), Lindhés Advokabyra AB Grant and Stohnes Stiftelse (LEAG, YAT), and the Spanish Ministerio de Ciencia e Innovación (MICIN/AEI/FEDER: PID2019-107677 GB-I00; ARM)., Peer reviewed